(Q43514773)

English

Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Hussain FN

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ajjan RA

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kapur K

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Moustafa M

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Riley SA

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

53-62

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Understanding and Improving Patient Compliance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

The effect of medication compliance on the control of hypertension

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00891.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2001.00891.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43514773&oldid=2143334455"